glp 1 agonist comparison chart equivalency Promising New Science on Weight Loss Drug Alternatives Products - Data Briefs -
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists, known for their effectiveness in managing diabetes by enhancing insulin secretion, are now under investigation for their potential impact on prostate cancer (PCa)
2018;8:e020445 Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ
Improvements in fibrosis were observed in up to 55% of patients, although these results did not consistently reach statistical significance
M6: \(\beta\)= 0.95, 95% CI 1.18, 0.72
Exercise timing also matters
Feb 22, 2026 Some people notice changes within days
